M DELENA

ANITA: Phase III adjuvant vinorelbine (N) and cisplatin (P) versus observation (OBS) in completely resected (stage I-III) non-small-cell lung cancer (NSCLC) patients (pts): Final results after 70-month median follow-up. On behalf of the Adjuvant Navelbine International Trialist Association

J.-Y. Douillard, R. Rosell, M DELENA et al. · Journal of Clinical Oncology · 2005 · 161 citations

Iiia Nsclc Pts, Surgical Oncology, Cancer Management +23

Cisplatin, dacarbazine, and fotemustine plus interferon α in patients with advanced malignant melanoma

Antonio Daponte, Paolo A. Ascierto, Adriano Gravina et al. · Cancer · 2000 · 23 citations

Cyclophosphamide, vincristine, and prednisone (CVP) versus adriamycin, bleomycin, and prednisone (ABP) in stage IV non‐Hodgkin's lymphomas

S. Monfardini, Gabriele Tancini, M DELENA et al. · Medical and Pediatric Oncology · 1977 · 18 citations

Lymphoid Neoplasia, Stage Iv Non‐hodgkin, Hepatology +15

RESULTS OF A CLINICAL MULTICENTRIC RANDOMIZED PHASE-II STUDY OF NONSMALL CELL LUNG-CANCER TREATED WITH VINORELBINE CISPLATIN VERSUS VINORELBINE ALONE

Vito Lorusso, G. Pezzella, Michele Guida et al. · International Journal of Oncology · 1995 · 12 citations

Multicentric Randomized Study, July 1992, Medicine +13

ORAL VERSUS INTRAVENOUS CMF IN METASTATIC BREAST-CANCER - A RANDOMIZED STUDY

M Brandi, A DEMITRIO, Paolo Ditonno et al. · International Journal of Oncology · 1994 · 10 citations

Breast Oncology, Medicine, Randomized Study +11